BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 23460706)

  • 1. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
    J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
    Chantada GL; Dunkel IJ; de Dávila MT; Abramson DH
    Br J Ophthalmol; 2004 Aug; 88(8):1069-73. PubMed ID: 15258027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a prospective study for the treatment of unilateral retinoblastoma.
    Chantada GL; Fandiño AC; Guitter MR; Raslawski EC; Dominguez JL; Manzitti J; de Dávila MT; Zubizarreta P; Scopinaro M
    Pediatr Blood Cancer; 2010 Jul; 55(1):60-6. PubMed ID: 20486172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
    Radhakrishnan V; Kashyap S; Pushker N; Sharma S; Pathy S; Mohanti BK; Vishnubhatla S; Ghose S; Bakhshi S
    Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM; Kingston J; Hungerford JL
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country.
    Suryawanshi P; Ramadwar M; Dikshit R; Kane SV; Kurkure P; Banavali S; Viswanathan S
    Arch Pathol Lab Med; 2011 Aug; 135(8):1017-23. PubMed ID: 21809993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.
    Sullivan EM; Wilson MW; Billups CA; Wu J; Merchant TE; Brennan RC; Haik BG; Shulkin B; Free TM; Given V; Rodriguez-Galindo C; Qaddoumi I
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e335-40. PubMed ID: 24577551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
    Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
    Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J; Piwowarczyk A; Romanowska-Dixon B; Balwierz W; Dłuzniewska A
    Klin Oczna; 2006; 108(1-3):55-9. PubMed ID: 16883942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
    Wilson MW; Haik BG; Billups CA; Rodriguez-Galindo C
    Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.